Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Agelenopsis pennsylvanica

ABSTRACT: Agelenopsis pennsylvanica Transcriptome or Gene expression

PROVIDER: PRJNA251572 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1329250_1.fastq.gz	Fastqsanger.gz
	SRR1329250_2.fastq.gz	Fastqsanger.gz
	SRR1329248_1.fastq.gz	Fastqsanger.gz
	SRR1329248_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Fraxinus pennsylvanica

Project description:Fraxinus pennsylvanica Transcriptome or Gene expression

| PRJNA167672 | ENA

Fraxinus pennsylvanica

Project description:Fraxinus pennsylvanica Transcriptome or Gene expression

| PRJNA273266 | ENA

Fraxinus pennsylvanica

Project description:Fraxinus pennsylvanica overview

| PRJNA167786 | ENA

ORG.one project - Fraxinus pennsylvanica

Project description:ORG.one project - Fraxinus pennsylvanica

| PRJEB47234 | ENA

Fraxinus pennsylvanica genome assembly v1.4

Project description:This study has produced an updated, chromosome-level assembly for Fraxinus pennsylvanica and a corresponding gene annotation.

| PRJEB46894 | ENA

Integrative analysis of green ash phloem transcripts and proteins during an emerald ash borer infestation

Project description:We performed RNA-seq and proteomics on naturally infested green ash (F. pennsylvanica) trees at low, medium and high levels of increasing emerald ash borer (A. planipennis) infestation. Our integrative analysis of the RNA-Seq and proteomics data identified 14 proteins and 4 transcripts that contribute most to the difference between highly infested and low infested trees.

2023-03-08 | GSE212332 | GEO

Phymata pennsylvanica

Project description:The 1KITE project: evolution of insects

| PRJNA272280 | ENA

Biomarks of Resistance to Cetuximab in Colorectal Cancer

Project description:Interventions: A group:Before using cetuximab;B group:After progression of disease:no Primary outcome(s): KRAS gene sequence;NRAS gene sequence;BRAF gene sequence;PIK3CA gene sequence;EGFR gene sequence;EGFR gene copy numbers;EGFR expression;Her2 expression;c-Met expression;PTEN expression Study Design: historical control

| 2671639 | ecrin-mdr-crc

A high-quality reference genome for Fraxinus pennsylvanica for ash species restoration and research.

Project description:Green ash (Fraxinus pennsylvanica) is the most widely distributed ash tree in North America. Once common, it has experienced high mortality from the non-native invasive emerald ash borer (EAB; Agrilus planipennis). A small percentage of native green ash trees that remain healthy in long-infested areas, termed "lingering ash," display partial resistance to the insect, indicating that breeding and propagating populations with higher resistance to EAB may be possible. To assist in ash breeding, ecology and evolution studies, we report the first chromosome-level assembly from the genus Fraxinus for F. pennsylvanica with over 99% of bases anchored to 23 haploid chromosomes, spanning 757 Mb in total, composed of 49.43% repetitive DNA, and containing 35,470 high-confidence gene models assigned to 22,976 Asterid orthogroups. We also present results of range-wide genetic variation studies, the identification of candidate genes for important traits including potential EAB-resistance genes, and an investigation of comparative genome organization among Asterids based on this reference genome platform. Residual duplicated regions within the genome probably resulting from a recent whole genome duplication event in Oleaceae were visualized in relation to wild olive (Olea europaea var. sylvestris). We used our F. pennsylvanica chromosome assembly to construct reference-guided assemblies of 27 previously sequenced Fraxinus taxa, including F. excelsior. Thus, we present a significant step forward in genomic resources for research and protection of Fraxinus species.

| S-EPMC9299157 | biostudies-literature

TR study of ‘multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer&quot

Project description:Primary outcome(s): Cancer-related gene alteration, expression of protein, and expression of RNA

| 2645675 | ecrin-mdr-crc